4.8 Article

An Asymmetric Reductase That Intercepts Acyclic Imino Acids Produced in Situ by a Partner Oxidase

Journal

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 141, Issue 31, Pages 12258-12267

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jacs.9b03307

Keywords

-

Funding

  1. U.S. Department of Energy
  2. National Institutes of Health
  3. Genome Canada
  4. Genome British Columbia [214PRO]
  5. University of British Columbia
  6. Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-03778]
  7. Alfred P. Sloan Foundation [FG-20166503]
  8. Canadian Institutes of Health Research [FDN-148381, 201312MSH-322191-209186]
  9. Michael Smith Foundation for Health Research [16776]

Ask authors/readers for more resources

Acyclic imines are unstable in aqueous conditions. For this reason, known imine reductases, which enable the synthesis of chiral amines, mainly intercept stable cyclic imines. Here we report the detailed biochemical and structural characterization of Bsp5, an imino acid reductase from the D-2-hydroxyacid dehydrogenase family that reduces acyclic imino acids produced in situ by a partner oxidase. We determine a 1.6 angstrom resolution structure of Bsp5 in complex with D-arginine and coenzyme NADPH. Combined with mutagenesis work, our study reveals the minimal structural constraints for its biosynthetic activity. Furthermore, we demonstrate that Bsp5 can intercept more complex products from an alternate oxidase partner, suggesting that this oxidaseimino acid reductase pair could be evolved for biocatalytic conversion of L-amino acids to D-amino acids.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available